SAVE THE DATE!! November 14, 2017 from 6:30 PM to 8:30 PM. Want the most cutting edge news after the largest global MS meeting called ECTRIMS in Paris? Barry Singer, MD and Mark Tullman, MD from The MS Center for Innovations in Care will present the most promising and impactful results. New information on multiple sclerosis treatment and myelin repair will be reviewed. RSVP at 314-996-LIFE.
This year the program will be on the CAMPUS of MISSOURI BAPTIST MEDICAL CENTER in the Clinical Learning Institute which is conveniently above the main garage next to the main entrance of the hospital (and in the same building at the Goldfarb School of Nursing).
Dr. Singer and Dr. Tullman co-chaired Walk MS this April to raise funds for the National Multiple Sclerosis Society (NMSS). The funding is critical for new multiple sclerosis research to stop disease progression, restore function, and end MS forever. Team MoBap was back in force to support NMSS and The MS Center for Innovations in Care in their mission to improve the lives of those living with multiple sclerosis.
You’re invited to our free annual program to hear about the latest in multiple sclerosis treatments including new exciting results in progressive disease. Groundbreaking research from the world’s largest annual international MS conference in mid September will be presented. An array of topics will be addressed including bone marrow transplant, stem cells and myelin repair. Question and answer session will follow. Light refreshments will be served.
Speakers: Barry Singer, MD; Mark Tullman, MD; Melanie Huff, BSN, RN.
THURSDAY October 6, 2016 6:30 to 8:30 PM, St. Louis Frontenac Hilton, 1335 South Lindbergh
REGISTER: 314-996-LIFE (314-996-5433) or 800-392-0936.
MS Program Flyer
Barry Singer, MD, our center’s director, continues to work hard to further our understanding of multiple sclerosis and advance treatment. He presented scientific posters at the Academy of Neurology Meeting in Vancouver in April 2016. Topics were the efficacy of using Lemtrada (alemtuzumab) in patients with highly active multiple sclerosis and rapid benefits of Gilenya (fingolimod) in relapsing forms of multiple sclerosis.
Dr. Singer also just published a chapter in Seminars in Neurology on FDA-approved and future monoclonal antibody treatments for multiple sclerosis. Tysabri (natalizumab) and Lemtrada (alemtuzumab) are currently available. Hopefully, both Ocrevus (ocrelizumab) and Zinbryta (daclizumab) will be available within the year. His chapter also covers remyelination antibodies being studied in clinical trials including opicinumab (Anti-LINGO-1) and rHIgM22.
In addition, Dr. Singer was extremely pleased to join the Board of Directors for the Multiple Sclerosis Association of America. As a global patient advocate, this position will allow him to further press for options for those living with multiple sclerosis.
From the MS Center for Innovations in Care, Danielle Scales, Dr. Singer, Vickie Kopf, and Delea Payne-Gates (left to right)
On April 17, 2016, Team MoBap had a great time participating in Walk MS with the Gateway Chapter of the National Multiple Sclerosis Society. Our team consisted of patients and staff committed to fundraising for critical research to repair MS damage and ultimately curing MS. Team MoBap was over 70 people strong and was the highest fundraising team. Dr. Barry Singer, the Walk MS chair, thanked the walkers and volunteers for their dedication and support!
Walk MS Speakers: Barry Singer, MD, Rebecca Fehlig, Chapter President of theGateway Chapter of National MS Society and Evelyn Sanguinetti, Illinois’ lieutenant governor living with MS (left to right)